rb 6145 has been researched along with perfosfamide in 1 studies
| Studies (rb 6145) | Trials (rb 6145) | Recent Studies (post-2010) (rb 6145) | Studies (perfosfamide) | Trials (perfosfamide) | Recent Studies (post-2010) (perfosfamide) |
|---|---|---|---|---|---|
| 38 | 0 | 2 | 328 | 18 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siemann, DW | 1 |
1 other study(ies) available for rb 6145 and perfosfamide
| Article | Year |
|---|---|
In vitro cytotoxicity and chemosensitizing activity of the dual function nitroimidazole RB 6145.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Humans; Lomustine; Mice; Nitroimidazoles; Prodrugs; Stereoisomerism; Tumor Cells, Cultured | 1994 |